A novel Alzheimer’s disease drug candidate targeting inflammation and fatty acid metabolism

BACKGROUND: CAD-31 is an Alzheimer’s disease (AD) drug candidate that was selected on the basis of its ability to stimulate the replication of human embryonic stem cell-derived neural precursor cells as well as in APPswe/PS1ΔE9 AD mice. To move CAD-31 toward the clinic, experiments were undertaken t...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Alzheimers Res Ther
Asıl Yazarlar: Daugherty, Daniel, Goldberg, Joshua, Fischer, Wolfgang, Dargusch, Richard, Maher, Pamela, Schubert, David
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2017
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5513091/
https://ncbi.nlm.nih.gov/pubmed/28709449
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-017-0277-3
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller